FDA Inspection 816766 — Nexus Pharmaceuticals, LLC

Nexus Pharmaceuticals, LLC — FEI 3005191225

The FDA completed an inspection of Nexus Pharmaceuticals, LLC on Jan 16, 2013 in Lincolnshire, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 16, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lincolnshire, IL (United States)